WO2000000586A1 - Bioreactor and cell culturing processes using the bioreactor - Google Patents
Bioreactor and cell culturing processes using the bioreactor Download PDFInfo
- Publication number
- WO2000000586A1 WO2000000586A1 PCT/US1999/014972 US9914972W WO0000586A1 WO 2000000586 A1 WO2000000586 A1 WO 2000000586A1 US 9914972 W US9914972 W US 9914972W WO 0000586 A1 WO0000586 A1 WO 0000586A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bioreactor
- culture vessel
- cells
- axis
- dome
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
- C12M27/10—Rotating vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/24—Gas permeable parts
Definitions
- the invention relates to a bioreactor and a method for culturing cells using the bioreactor. More particularly, the invention is directed to a bioreactor having a dome- shaped culture vessel that rotates about its axis of symmetry set on a substantially horizontal plane and a method for culturing cells in that bioreactor.
- a sample of cells is generally placed in a vessel, provided with nutrients, and agitated. After a sufficient period of time to allow production and growth of new cells, the cultured cells are removed from the vessel and purified.
- small-scale cell culturing has traditionally been performed in shallow shaker flasks. The cells and nutrient media are combined in the flask and a mechanical or magnetic stirring mechanism circulates the mixture. This circulation is important to prevent the cells from settling to the bottom of the culture vessel due to gravity and to ensure sufficient nutrient transfer to and waste bioproducts from the growing cells.
- 5,026,650 (Schwartz., issued June 25, 1991); 5,155,034 (Wolf et al., issued October 13, 1992); and 5,153,133 (Schwartz et al., issued October 6, 1992) disclose a bioreactor having a horizontally disposed cylindrical culture vessel that rotates about its longitudinal axis.
- the vessel contains a coaxially-disposed, oxygen- permeable membrane and access ports to inject or withdraw nutrient media.
- U.S. Patent No. 5,151,368 (Brimhall et al., issued September 29, 1992) describes a dual-axis continuous flow bioreactor for handling high solids loaded materials such as coal and mineral ores.
- the bioreactor is mounted to a horizontal axle, corresponding to the bioreactor' s longitudinal axis, and moves in a circular path about its vertical shaft while simultaneously rotating about its horizontal axis by an interlocking set of bevel ring gears.
- the vessel contains several conduits for introducing and withdrawing media and gases.
- U.S. Patent No. 5,565,361 (Mutsakis et al., issued October 15, 1996) describes a bioreactor containing a porous, fibrous sheet material that acts as a motionless mixing element and as a substrate for attaching the cultivating cells.
- U.S. Patent No. 5,622,857 (Goffe, issued April 22, 1997) describes a bundled hollow fiber bioreactor and its use to prepare eucaryotic cells. The flow of oxygenated nutrient medium is maintained at a sufficient pressure to prevent the formation of bubbles that may block flow of media through the fibers.
- 5,688,687 (Palsson et al., issued November 18, 1997) describes a bioreactor for mammalian cell growth having a circular cell growth chamber between a planar cell bed and a gas permeable membrane. Media inlet and outlets are arranged in a concentric circular arrangement and provide for the delivery of nutrients to the cells.
- U.S. Patent No. 5,605,835 (Hu et al., issued February 25, 1997) describes a bioreactor that immobilizes animal cells in an insoluble, biocompatible matrix. Selective membranes allow for the separation of cell nutrients and cell wastes while collecting the desired cell products within the cell chamber.
- This invention relates to a bioreactor and a cell culturing method that use the bioreactor. More particularly, the invention is directed to a bioreactor having a dome- shaped culture vessel that rotates about its axis of symmetry set on a substantially horizontal plane and a method for culturing cells in that bioreactor.
- the inventive bioreactor comprises a dome-shaped culture chamber having walls defining an interior volume and a circular ridge at the bottom of the chamber.
- the circular ridge of the culture chamber is fluidtightly integrated with a gas permeable membrane.
- the membrane side of the culture chamber may be fluidtightly integrated with a rotating base in an orientation where the axis of symmetry of the dome-shaped culture chamber is substantially horizontal.
- the dome-shaped design and horizontal orientation provide a low shear environment and mass transfer that is favorable for culturing cells, particularly mammalian cells that form multicellular aggregates for the production of large biomasses.
- the method according to the invention comprises providing the inventive bioreactor, adding cells and appropriate nutrients to the interior volume of the dome- shaped culture chamber, and rotating the base at a rate that generates suitable mass transfer and low shear stress.
- the bioreactor comprises additional features that permit efficient addition of cell samples and removal of cell product, efficient addition and removal of nutrients and gases, easy assembly of the bioreactor components, and a flexible design to allow for a wide variety of cell cultures and culturing conditions.
- FIG. 1 is a schematic diagram a bioreactor having a dome-shaped culture vessel.
- FIG. 2 is a schematic drawing of a bioreactor having a culture vessel with an alternative dome-shaped design.
- FIG. 3 is a schematic drawing of a bioreactor having a culture vessel with another alternative dome-shaped design.
- the bioreactor according to the invention has a dome-shaped culture vessel that rotates about its axis of symmetry set on a substantially horizontal plane.
- the circular ridge of the culture chamber is fluidtightly integrated with a gas-permeable membrane.
- the membrane-side of the culture chamber may be fluidtightly integrated with a rotating base in an orientation where the axis of symmetry of the dome-shaped culture chamber is substantially horizontal.
- the dome-shaped design and horizontal orientation provide a low shear environment and mass transfer that is favorable for culturing cells, particularly mammalian cells that form multicellular aggregates for the production of large biomasses.
- dome-shaped in the context of describing the culture vessel, means having the shape of a dome or cone, or a shape that substantially resembles a dome or cone. That is, the bottom of the vessel has a circular ridge, the vessel's axis of symmetry is perpendicular to the circular ridge and the walls of the vessel extend to an apex.
- the walls of the vessel leading to the apex are, for at least a portion, concave; the walls can have a partial non-curved portion.
- the apex can be a single point at the peak of the curved walls or can be a level surface at the peak of the curved walls.
- FIGS. 1-3 are identical to FIGS. 1-3.
- substantially horizontal in the context of describing the orientation of the axis of symmetry of the dome-shaped culture chamber, means that the axis is no more than 20 degrees from the horizontal plane. In a further preferred embodiment, the axis of symmetry is set no more than 10 degrees from the horizontal plane and, ideally, is in a horizontal plane.
- the inventive bioreactor comprises a dome-shaped culture chamber 1 having an interior volume 2, a bottom circular ridge 3, walls having at least a partially curved surface 4 and an apex 5.
- the circular ridge of the culture chamber is fluidtightly integrated with a gas-permeable membrane 6.
- the membrane-side of the culture chamber is fluidtightly integrated with a rotating base 7 in an orientation where the axis of symmetry of the dome-shaped culture chamber 8 is substantially horizontal.
- the dome-shaped culture chamber can have a variety of shapes, as exemplified by the alternative dome-shapes depicted in FIGS. 1, 2, and 3.
- the culture chamber can be made of any material that is compatible with the culturing system, including glass, plastic, or stainless steel.
- the vessel comprises a material that can be sterilized by ethylene oxide, gamma irradiation, or autoclaving, or, alternatively, is disposable.
- the interior volume 2 of the culture vessel can vary greatly, depending upon the types of cells, amount of cells to be produced and available laboratory space.
- the volume of the substantially dome-shaped vessel is between about 10 mL and about 10 L.
- Small and medium scale laboratory cultures can preferably be performed in vessels of 100 mL, 250 mL, and 500 mL volumes. Larger preparative scale cultures can preferably be performed in vessels of 1 L, 5 L, and 10 L volumes.
- the gas permeable material 3 can generally be any material compatible with the culturing system, i.e., to allow flow of appropriate gases and to restrict flow of cells and liquid nutrients across the membrane.
- the gas permeable membrane can comprise polytetrafluoroethylene, polyethylene, or porous hydrophobic TEFLON® membrane.
- the gas permeable membrane may additionally allow flow of liquids, nutrients, and metabolites across the membrane.
- the bioreactor can further comprise an access port or a plurality of access ports to the culture vessel 9, 10, 11.
- the access ports allow transfer of materials and gases into and out of the bioreactor.
- Access ports can lead to the surface of the gas-permeable membrane 10 or can lead directly into the culture vessel 9, 11.
- the access ports leading directly into the culture vessel can go through the gas permeable membrane 9 or can go through the wall or apex of the culture vessel 11.
- the access ports can be any type of port used with culture or reaction vessels, including valves and membranes that can be penetrated by tubing, syringe, pipette or other sampling device.
- the bioreactor can further comprise a agitator within the culture vessel 12.
- This agitator can be any type of device that provides additional agitation to the culture mixture, including a magnetic spinner or a mechanically driven propeller 12.
- the invention is further directed to a method for culturing cells.
- the method according to the invention comprises providing the inventive bioreactor, adding cells and appropriate nutrients to the interior volume of the dome-shaped culture chamber, and rotating the base at a rate that generates suitable mass transfer and low shear stress. Where the mass transfer of the culture solution is provided by both the rotation of the culture chamber and by spinning an agitator in the culture vessel, the combined effects of these means must be weighed in determining the respective rotation rates.
- the culturing of cells is preferably performed under conditions that optimize mass transfer and create low shear forces.
- the culturing cells are subjected to average shear forces of less than about 1 dyne/cm 2 , more preferably less than about 0.75 dyne/cm 2 , and most preferably less than about 0.5 dyne/cm 2 .
- the bioreactor and culturing method according to the invention can be use for culturing any type of cell.
- the cells are eucaryotic cells, preferably mammalian cells.
- the cells can be adherent cells or non-adherent cells, single cells or multicellular aggregates.
- Adherent cells are attached to a substrate, such as microca ⁇ ers, fibrous supports or other cells.
- the culturing method further comprise adding nutrients that enhance cell production and growth and removing waste products from the culturing process.
- the gases are transferred across the gas permeable membrane 3.
- gases, nutrients or cell samples can be extracted from a port extending through the gas permeable membrane 9 or other access ports in the culture vessel wall or at its apex 11.
- gas bubbles can be removed or culture fluid samples taken from an access port at the culture vessel apex to avoid disrupting the operation of the bioreactor.
- the culture vessel can be temporarily tilted to position the apex of the culture vessel so that bubbles rise to the apex access port.
- a bioreactor can be designed with the following dimensions.
- the rotating base has a perfluorocarbon chamber of 60 mL volume for oxygenation, nutrient inlet and outlet ports.
- the dome- shaped culture vessel of 125 mL volume is filled with culture medium into which aggregates of cells and microcarrier beads were introduced.
- the rates of rotation of the vessel and spinner are limited to a range in which the radial, circumferential, and axial velocity were large enough to suspend particles and provide adequate mixing, but small enough to prevent turbulence.
- Relative rotation rates may be determined and optimized by simulating flow fields with software such as FLUENT or FIDAP (both are commercially available from Fluent, Inc., Riverside, NH).
- FLUENT or FIDAP both are commercially available from Fluent, Inc., Riverside, NH.
- the unique advantage of this rotational perfused hemispherical bioreactor is that the fluid shear force created by the differential rate of rotation of the dome and spinner would be more uniform and controllable.
- the rates of rotation of the concave shaped vessel and spinner were limited to a range in which the radial, circumferential, and axial velocity were large enough to suspend particles and provide adequate mixing, but small enough to prevent turbulence.
- the unique advantage of this bioreactor was that the fluid shear force created by the differential rate of rotation of the dome and spinner would be more uniform and controllable.
- compositions, methods, and apparatus can be made and executed without undue experimentation in light of the present disclosure. While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations can be applied to the compositions, methods, and apparatus and in the steps or in the sequence of steps of the methods described herein without departing from the concept, spirit and scope of the invention. More specifically, it will be apparent that certain agents which are both chemically and physiologically related can be substituted for the agents described herein while the same or similar results would be achieved. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention.
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Clinical Laboratory Science (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99933649A EP1093513A4 (en) | 1998-06-29 | 1999-06-28 | Bioreactor and cell culturing processes using the bioreactor |
CA002336062A CA2336062C (en) | 1998-06-29 | 1999-06-28 | Bioreactor and cell culturing processes using the bioreactor |
AU49657/99A AU4965799A (en) | 1998-06-29 | 1999-06-28 | Bioreactor and cell culturing processes using the bioreactor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/106,987 US6001642A (en) | 1998-06-29 | 1998-06-29 | Bioreactor and cell culturing processes using the bioreactor |
US09/106,987 | 1998-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000000586A1 true WO2000000586A1 (en) | 2000-01-06 |
WO2000000586A9 WO2000000586A9 (en) | 2000-12-14 |
Family
ID=22314273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/014972 WO2000000586A1 (en) | 1998-06-29 | 1999-06-28 | Bioreactor and cell culturing processes using the bioreactor |
Country Status (5)
Country | Link |
---|---|
US (1) | US6001642A (en) |
EP (1) | EP1093513A4 (en) |
AU (1) | AU4965799A (en) |
CA (1) | CA2336062C (en) |
WO (1) | WO2000000586A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007076865A1 (en) * | 2005-12-30 | 2007-07-12 | Drugmode Aps | Bioreactor for cell and tissue culture |
US8993231B2 (en) | 2008-03-18 | 2015-03-31 | Marshall University Research Corporation | Methods for stem cell production and therapy |
CN111100790A (en) * | 2019-12-31 | 2020-05-05 | 黄山市中新生物科技有限公司 | Cell culture bioreactor |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050266548A1 (en) * | 1995-03-28 | 2005-12-01 | Kbi Biopharma, Inc. | Biocatalyst chamber encapsulation system for bioremediation and fermentation with improved rotor |
US6720178B1 (en) | 2000-06-29 | 2004-04-13 | University Of Louisville Research Foundation, Inc. | Self-feeding roller bottle |
US6607910B1 (en) * | 2000-11-13 | 2003-08-19 | Synthecon, Inc. | Two chamber cell culture vessel |
US6642019B1 (en) | 2000-11-22 | 2003-11-04 | Synthecan, Inc. | Vessel, preferably spherical or oblate spherical for growing or culturing cells, cellular aggregates, tissues and organoids and methods for using same |
US6589780B2 (en) | 2000-12-15 | 2003-07-08 | Council Of Scientific And Industrial Research | Bio-reactor for enhancing the biomass yield of plant organs |
US6403369B1 (en) | 2001-01-19 | 2002-06-11 | Gary W. Wood | Cell culture vessel |
US6867040B2 (en) * | 2001-03-02 | 2005-03-15 | Charles E. Helmstetter | Bioreactor and methods for producing synchronous cells |
US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
US8105580B2 (en) | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
US7651684B2 (en) | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
CA2469370C (en) | 2001-12-07 | 2014-07-08 | Macropore Biosurgery, Inc. | Adipose-derived cell processing unit |
US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
US7585670B2 (en) | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
US6986505B2 (en) * | 2002-01-24 | 2006-01-17 | Platt Robert E | Adjustable fence rail mounting clip |
CN1300297C (en) * | 2002-09-20 | 2007-02-14 | 华东理工大学 | Digestive reactor for animal cell extension inoculation |
MXPA05009044A (en) | 2003-02-20 | 2006-03-17 | Macropore Biosurgery Inc | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions. |
BRPI0411798A (en) | 2003-06-25 | 2006-08-08 | Macropore Biosurgery Inc | systems and methods for separating and concentrating regenerative cells from tissue |
CN1878470A (en) | 2003-09-17 | 2006-12-13 | 马克罗珀尔生物外科公司 | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
US20050095700A1 (en) * | 2003-11-03 | 2005-05-05 | Thomas Budzowski | Method for maintaining low shear in a bioprocessing system |
JP2007529515A (en) | 2004-03-19 | 2007-10-25 | サイトリ セラピューティクス インコーポレイテッド | Cell carrier containing regenerative cells and cell carrier containment device |
US20050244957A1 (en) * | 2004-04-29 | 2005-11-03 | Healthy Soils, Inc. | Regenerating tank |
JP4937119B2 (en) | 2004-07-01 | 2012-05-23 | サイトリ セラピューティクス インコーポレイテッド | Methods of using regenerative cells for the treatment of musculoskeletal diseases |
ES2364957T3 (en) | 2004-07-01 | 2011-09-19 | Cytori Therapeutics, Inc. | PROCEDURES FOR THE USE OF REGENERATIVE CELLS TO PROMOTE WOUND CICATRIZATION. |
US7368279B2 (en) * | 2004-11-24 | 2008-05-06 | The Regents Of The University Of Michigan | Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor |
KR101400544B1 (en) | 2005-05-25 | 2014-05-27 | 사이토리 테라퓨틱스, 인크. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
WO2007115123A2 (en) * | 2006-03-30 | 2007-10-11 | Mark Clarke | Mineralized three-dimensional bone constructs |
KR100761922B1 (en) | 2006-04-07 | 2007-10-04 | 양현진 | Proliferation culture methods using micro-scaffolds for regulations of cell-to-cell signals |
US9057044B2 (en) | 2006-08-30 | 2015-06-16 | Meir Israelowitz | Laminar flow reactor |
US20080138828A1 (en) * | 2006-12-08 | 2008-06-12 | Marshall University Research Corporation | Microgravity bioreactor systems for production of bioactive compounds and biological macromolecules |
US20110033887A1 (en) * | 2007-09-24 | 2011-02-10 | Fang Nicholas X | Three-Dimensional Microfabricated Bioreactors with Embedded Capillary Network |
WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
US9316632B2 (en) | 2009-03-17 | 2016-04-19 | Marshall University Research Corporation | Methods of screening chemotherapeutic agents and treating cancer |
ES2625893T3 (en) | 2009-05-01 | 2017-07-20 | Bimini Technologies Llc | Systems, procedures and compositions to optimize grafts enriched with tissue and cells |
US9862923B2 (en) | 2010-03-26 | 2018-01-09 | Philip Morris Usa Inc. | Cultured tobacco cells as a matrix for consumable products |
WO2012003465A2 (en) | 2010-07-01 | 2012-01-05 | The Regents Of The University Of Michigan | Scaffold-free three dimensional nerve fibroblast constructs |
US11311367B2 (en) | 2012-01-31 | 2022-04-26 | Wake Forest University Health Sciences | Tissue-engineered gut-sphincter complexes and methods of making the same |
US20160022873A1 (en) | 2013-03-14 | 2016-01-28 | Research Institute At Nationwide Children's Hospital, Inc. | Tissue engineered intestine |
US20150017714A1 (en) | 2013-07-02 | 2015-01-15 | Miltenyi Biotec Gmbh | Centrifugation chamber with gas permeable membrane layers for cell cultivation |
ES2755741T3 (en) * | 2013-07-02 | 2020-04-23 | Miltenyi Biotec Bv & Co Kg | Centrifugation chamber with layers of gas-permeable membranes for cell culture |
EP2821144A1 (en) * | 2013-07-02 | 2015-01-07 | Miltenyi Biotec GmbH | Centrifugation chamber with gas-permeable membrane for cell cultivation |
US20150182558A1 (en) * | 2014-01-02 | 2015-07-02 | PSC Cosmetics Ltd. | Method and apparatus for harvesting, creating and implanting a fibrin clot biomaterial |
US20190015190A1 (en) | 2015-12-30 | 2019-01-17 | Wake Forest University Health Sciences | Tissue-engineered gut-sphincter complexes and methods of making the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5153131A (en) * | 1990-12-11 | 1992-10-06 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | High aspect reactor vessel and method of use |
US5523228A (en) * | 1995-07-07 | 1996-06-04 | Hmri/Clmf | Hydrodynamic cell culture environment for three dimensional tissue growth |
US5702941A (en) * | 1993-09-09 | 1997-12-30 | Synthecon, Inc. | Gas permeable bioreactor and method of use |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1369593A (en) * | 1970-09-17 | 1974-10-09 | Wellcome Found | Culture apparatus |
CH563456A5 (en) * | 1972-08-18 | 1975-06-30 | Mueller Hans Maennedorf | |
IT1097442B (en) * | 1977-08-18 | 1985-08-31 | Guigan Jean | CONDITIONING DEVICE OF A LIQUID SAMPLE IN PREPARATION OF ITS ANALYSIS |
AU6156780A (en) * | 1979-08-24 | 1981-04-09 | G.D. Searle & Co. | Stack plate culture |
CH647547A5 (en) * | 1982-02-12 | 1985-01-31 | Chemap Ag | METHOD AND DEVICE FOR BREEDING MICROORGANISMS. |
DE3600487A1 (en) * | 1986-01-10 | 1987-07-16 | Gebhardt Rolf | PERIFUSION DEVICE FOR BREEDING LIVING CELLS AND METHOD FOR PERIFUSION CULTURE |
US4846786A (en) * | 1987-04-30 | 1989-07-11 | Massachusetts Institute Of Technology | Bioreactor containing suspended, immobilized species |
US5605835A (en) * | 1988-05-23 | 1997-02-25 | Regents Of The University Of Minnesota | Bioreactor device with application as a bioartificial liver |
US4988623A (en) * | 1988-06-30 | 1991-01-29 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Rotating bio-reactor cell culture apparatus |
US5308764A (en) * | 1988-06-30 | 1994-05-03 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Multi-cellular, three-dimensional living mammalian tissue |
US5026650A (en) * | 1988-06-30 | 1991-06-25 | The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration | Horizontally rotated cell culture system with a coaxial tubular oxygenator |
US5155034A (en) * | 1988-06-30 | 1992-10-13 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Three-dimensional cell to tissue assembly process |
CA1307225C (en) * | 1988-07-19 | 1992-09-08 | David W. Armstrong | Cell culture bioreactor |
US5151368A (en) * | 1991-01-11 | 1992-09-29 | Technical Research Associates, Inc. | Dual axis, continuous flow bioreactor apparatus |
US5476783A (en) * | 1992-03-23 | 1995-12-19 | Koch Engineering Company, Inc. | Bioreactor method of culturing and propagating cells with a woven motionless mixing element |
US5330908A (en) * | 1992-12-23 | 1994-07-19 | The United States Of America As Represented By The Administrator, National Aeronautics And Space Administration | High density cell culture system |
US5686301A (en) * | 1993-09-02 | 1997-11-11 | Heraeus Instruments Gmbh | Culture vessel for cell cultures |
US5763279A (en) * | 1993-09-09 | 1998-06-09 | Synthecon, Inc. | Gas permeable bioreactor and method of use |
US5437998A (en) * | 1993-09-09 | 1995-08-01 | Synthecon, Inc. | Gas permeable bioreactor and method of use |
US5622857A (en) * | 1995-08-08 | 1997-04-22 | Genespan Corporation | High performance cell culture bioreactor and method |
US5688687A (en) * | 1995-06-07 | 1997-11-18 | Aastrom Biosciences, Inc. | Bioreactor for mammalian cell growth and maintenance |
US5928936A (en) * | 1997-04-09 | 1999-07-27 | Huntington Medical Research Institutes | Cell culture container that self-seals after cannula penetration made of porous sheets |
-
1998
- 1998-06-29 US US09/106,987 patent/US6001642A/en not_active Expired - Lifetime
-
1999
- 1999-06-28 WO PCT/US1999/014972 patent/WO2000000586A1/en not_active Application Discontinuation
- 1999-06-28 CA CA002336062A patent/CA2336062C/en not_active Expired - Lifetime
- 1999-06-28 AU AU49657/99A patent/AU4965799A/en not_active Abandoned
- 1999-06-28 EP EP99933649A patent/EP1093513A4/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5153131A (en) * | 1990-12-11 | 1992-10-06 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | High aspect reactor vessel and method of use |
US5702941A (en) * | 1993-09-09 | 1997-12-30 | Synthecon, Inc. | Gas permeable bioreactor and method of use |
US5523228A (en) * | 1995-07-07 | 1996-06-04 | Hmri/Clmf | Hydrodynamic cell culture environment for three dimensional tissue growth |
Non-Patent Citations (1)
Title |
---|
See also references of EP1093513A4 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007076865A1 (en) * | 2005-12-30 | 2007-07-12 | Drugmode Aps | Bioreactor for cell and tissue culture |
US8993231B2 (en) | 2008-03-18 | 2015-03-31 | Marshall University Research Corporation | Methods for stem cell production and therapy |
CN111100790A (en) * | 2019-12-31 | 2020-05-05 | 黄山市中新生物科技有限公司 | Cell culture bioreactor |
CN111100790B (en) * | 2019-12-31 | 2022-09-02 | 黄山市中新生物科技有限公司 | Cell culture bioreactor |
Also Published As
Publication number | Publication date |
---|---|
EP1093513A1 (en) | 2001-04-25 |
EP1093513A4 (en) | 2002-04-24 |
CA2336062C (en) | 2009-04-07 |
US6001642A (en) | 1999-12-14 |
AU4965799A (en) | 2000-01-17 |
WO2000000586A9 (en) | 2000-12-14 |
CA2336062A1 (en) | 2000-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6001642A (en) | Bioreactor and cell culturing processes using the bioreactor | |
US5026650A (en) | Horizontally rotated cell culture system with a coaxial tubular oxygenator | |
US5155035A (en) | Method for culturing mammalian cells in a perfused bioreactor | |
US5002890A (en) | Spiral vane bioreactor | |
US5523228A (en) | Hydrodynamic cell culture environment for three dimensional tissue growth | |
US5153131A (en) | High aspect reactor vessel and method of use | |
Martin et al. | Bioreactors for tissue mass culture: design, characterization, and recent advances | |
US5443985A (en) | Cell culture bioreactor | |
US5155034A (en) | Three-dimensional cell to tissue assembly process | |
US5308764A (en) | Multi-cellular, three-dimensional living mammalian tissue | |
CA2186492C (en) | Bioreactor | |
Mitteregger et al. | Rotary cell culture system (RCCS): a new method for cultivating hepatocytes on microcarriers | |
US5008197A (en) | Process and a device for improved oxygenation of biological cultures | |
GB2059436A (en) | Propagation of cells | |
JPH0640816B2 (en) | Agitator suitable for fermentation and tissue culture vessels | |
MXPA06011837A (en) | Stirred-tank reactor system. | |
US4840905A (en) | Process for culturing biological material | |
US5705390A (en) | Bioreactor | |
US6087158A (en) | Method and apparatus for growing cells using gas or liquid aphrons | |
JP3493200B2 (en) | Continuous settling device | |
Matsuura | Bioreactors for 3-dimensional high-density culture of human cells | |
CN101724557B (en) | Polysaccharide composite stent perfusion type liver cell reactor system for use in medicament-induced hepatotoxicity evaluation | |
Schwarz et al. | Rotating bio-reactor cell culture apparatus | |
RU2355751C1 (en) | Vortex reactor for carrying out biotechnological processes under microgravity conditions | |
Malik et al. | Large-Scale Culture of Mammalian Cells for Various Industrial Purposes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/3-3/3, DRAWINGS, REPLACED BY NEW PAGES 1/3-3/3; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
ENP | Entry into the national phase |
Ref document number: 2336062 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999933649 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999933649 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999933649 Country of ref document: EP |